Trulicity (dulaglutide) and Mounjaro (tirzepatide) are prescribed to help manage blood sugar in people with type 2 diabetes. Trulicity also has other uses. Both drugs come as an injection that you ...
Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to ...
In the AWARD-7 trial, patients who received Trulicity 0.75mg or 1.5mg in combination with mealtime insulin lispro achieved similar glycemic control with weight loss vs patients who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results